Dendritic cell, the immunotherapeutic cell for cancer.
Artículo
en Inglés
| IMSEAR
| ID: sea-21204
ABSTRACT
Dendritic cells play an important role in the development of effective cancer vaccines. These cells have the potential to present tumour-specific antigens and thereby induce an immune response. Various studies involving clinical trials have investigated the efficacy of administering antigen-loaded dendritic cells for cancer therapy. In order to design such experiments it is important to consider specific antigens, which initiate either a CD4+ or CD8+ response or both. The present review discusses the unique properties of dendritic cells as an immunotherapeutic cell for cancer.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Péptidos
/
Células Dendríticas
/
Humanos
/
Vacunas
/
Transfección
/
Linfocitos T CD4-Positivos
/
Ensayos Clínicos como Asunto
/
Linfocitos T CD8-positivos
/
Inmunoterapia
/
Antígenos de Neoplasias
Idioma:
Inglés
Año:
2004
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS